Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC

Rank in Stocks #23695
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
Share Price
$1.02
Last synced: 2026-11-17
Market Cap
$38.58M
Change (1 day)
-0.24%
Change (1 year)
5.03%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for Arecor Therapeutics plc (AREC)
Operating Margin as of November 2026 TTM: 5,113.68%
According to Arecor Therapeutics plc's latest financial reports, its current operating margin (TTM) is 5,113.68%. At the end of 2025 the company had an operating margin of -272.23%.
Operating Margin history for Arecor Therapeutics plc from 2017 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 5,113.68% -1,978.44%
2025 -272.23% 28.59%
2024 -211.70% 5.52%
2023 -200.63% -58.65%
2022 -485.23% -5.99%
2021 -516.15% 155.61%
2020 -201.93% 42.04%
2019 -142.16% 37.31%
2018 -103.53% 0.00%
2017 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -100.04%
US
33.87% -99.99%
US
-116.04% -100.02%
US
25.57% -99.99%
AU
31.23% -99.99%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Arecor Therapeutics plc's operating margin

What is Arecor Therapeutics plc's operating margin?

Arecor Therapeutics plc's operating margin is 5,113.68%, as of Nov 2026.

What was Arecor Therapeutics plc's operating margin in 2025?

In 2025, Arecor Therapeutics plc's operating margin was -272.23%, compared with -211.70% in 2024.

How has Arecor Therapeutics plc's operating margin changed since 2020?

From 2020 to 2025, Arecor Therapeutics plc's operating margin was highest in 2023 (-200.63%) and lowest in 2021 (-516.15%).

How does Arecor Therapeutics plc's operating margin compare with similar companies?

Arecor Therapeutics plc's operating margin (5,113.68%) is higher than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.